Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02197169
Title DNX-2401 With Interferon Gamma (IFN-gamma) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors (TARGET-I)
Acronym TARGET-I
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors DNAtrix, Inc.
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.